Patent application number | Description | Published |
20120211168 | PROTECTIVE MATERIAL APPLICATOR DEVICE - Devices, methods and systems disclosed herein relate to the application of a protective film on a surface of an electronic device that instantly reduces air bubbles and eliminates the waiting time usually required when using a wet fluid solution. In one embodiment, a roller device may include a carriage or housing and one or more rollers coupled or integrated with the housing, configured to apply a protective material to a surface of the electronic device in a first orientation, and configured to function as a device stand in a second orientation. In addition or alternatively, a roller guide apparatus and/or a wedge may be utilized to assist the roller device in applying the protective material to the surface of the electronic device. | 08-23-2012 |
20120211170 | PROTECTIVE MATERIAL APPLICATOR DEVICE - Devices, methods and systems disclosed herein relate to the application of a protective film on a surface of an electronic device instantly reducing air bubbles and eliminating the waiting time usually required when using a wet fluid solution. In one embodiment, a roller device may include a carriage or housing and one or more rollers coupled or integrated with the housing, configured to apply a protective material to a surface of the electronic device in a first orientation, and configured to function as a device stand in a second orientation. | 08-23-2012 |
20120211171 | PROTECTIVE MATERIAL APPLICATOR DEVICE - Devices, methods and systems disclosed herein relate to the application of a protective film on a surface of an electronic device that instantly reduces air bubbles and eliminates the waiting time usually required when using a wet fluid solution. In one embodiment, a well apparatus graspable by a user's hand for receiving any of a plurality of mobile communication device inserts is provided. Each of the plurality of mobile communication device inserts may have a mobile communication device receiving cavity of a different shape or size configured to receive a mobile communication device of a particular shape and size. After inserting a mobile communication device insert into the well apparatus, a user may insert a mobile communication device into the receiving cavity and apply a protective layer with a roller. | 08-23-2012 |
20120302297 | ADHESIVE CASE FOR A MOBILE COMMUNICATION DEVICE - Devices, methods and systems are directed to a top protection portion and a bottom protection portion to protect a front exterior and a back exterior, respectively, of a mobile communication. The top protection portion and the bottom protection portion may each include one or more adhesive members. The adhesive members may be designed to allow a user to remove and apply the top protection portion and the bottom protection portion as desired (e.g., to access a concealed battery of the mobile communication device) without losing their adhesive property. | 11-29-2012 |
20120312847 | UNIVERSAL ELECTRONIC DEVICE HOLDER ATTACHABLE TO HEADREST BARS - Devices, methods and systems described herein provide for removably attaching an electronic device holder to a set of headrest bars of a seat in a vehicle in a manner which allows the user, while seated in the backseat of the vehicle, to utilize the electronic device without holding the electronic device. | 12-13-2012 |
20140124146 | PROTECTIVE MATERIAL APPLICATOR DEVICE - Devices, methods and systems disclosed herein relate to the application of a protective film on a surface of an electronic device that instantly reduces air bubbles and eliminates the waiting time usually required when using a wet fluid solution. In one embodiment, a flange may be configured to couple to the protective film. The flange may aid in the accurate application of the protective film to the electronic device. | 05-08-2014 |
20140243054 | MOBILE DEVICE CASE WITH CUSHION DEVICES - A case for a mobile device including a base wall and a plurality of side walls extending from the base wall to cover side surfaces of the mobile device. A plurality of cushion devices may pass through the side walls to cushion the mobile device from a force exerted upon the case. | 08-28-2014 |
20140332418 | SHELL WITH KICKSTAND - An apparatus and/or systems related to a case for a mobile device. A protective case may include a stand portion which slides out to an open position for propping up the mobile device at a predetermined angle for viewing by a user. As the user switches the viewing orientation of the mobile device (e.g., by physically rotating the mobile device 90 degrees), the stand portion continues to prop up the mobile device at the predetermined angle. | 11-13-2014 |
20150246515 | PROTECTIVE MATERIAL APPLICATOR DEVICE - Devices, methods and systems disclosed herein relate to the application of a protective film on a surface of an electronic device that instantly reduces air bubbles and eliminates the waiting time usually required when using a wet fluid solution. In one embodiment, a flange may be configured to couple to the protective film. The flange may aid in the accurate application of the protective film to the electronic device. | 09-03-2015 |
Patent application number | Description | Published |
20100316594 | MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 12-16-2010 |
20130315862 | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS - A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided. | 11-28-2013 |
20130315863 | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE INFECTIONS - A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided. | 11-28-2013 |
Patent application number | Description | Published |
20110129813 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION - The present invention discloses a method for the treatment of Flaviviridae infection that includes the administration of a 2′-branched nucleoside, or a pharmaceutically acceptable prodrug and/or salt thereof, to a human in need of therapy in combination or alternation with a drug that directly or indirectly induces a mutation in the viral genome at a location other than a mutation of a nucleotide that results in a change from serine to a different amino acid in the highly conserved consensus sequence, XRX | 06-02-2011 |
20130330297 | MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 12-12-2013 |
20140113880 | MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 04-24-2014 |
20140213540 | MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 07-31-2014 |
20140286900 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION - The present invention discloses a method for the treatment of Flaviviridae infection that includes the administration of a 2′-branched nucleoside, or a pharmaceutically acceptable prodrug and/or salt thereof, to a human in need of therapy in combination or alternation with a drug that directly or indirectly induces a mutation in the viral genome at a location other than a mutation of a nucleotide that results in a change from serine to a different amino acid in the highly conserved consensus sequence, XRX | 09-25-2014 |
20150017124 | MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 01-15-2015 |